Approximately 44% of homeless adults are hepatitis C virus (HCV)-infected.1- 5 Historically, homeless and marginally housed (HMH) adults have faced barriers to HCV treatment. New, interferon-free therapies have excellent cure rates and improved tolerability, reducing barriers for treatment.6 To our knowledge, no published studies have documented the treatment of HMH populations with these therapies. The Boston Health Care for the Homeless Program (BHCHP) began treating HMH adults with oral agents in 2014.
Joshua A. Barocas, Marguerite Beiser, Casey León, Jessie M. Gaeta, James J. O’Connell, Benjamin P. Linas. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017;177(6):880–882. doi:10.1001/jamainternmed.2017.0358